Pneumonia
Community-acquired pneumonia is a lower respiratory tract infection diagnosed by fever with cough, dyspnea, or chest pain plus a new infiltrate on chest imaging, with Streptococcus pneumoniae, respiratory viruses, and atypical organisms as leading causes. Site of care is guided by the Pneumonia Severity Index or IDSA/ATS criteria, outpatient therapy is amoxicillin or doxycycline, and hospitalized patients receive a beta-lactam plus a macrolide or a respiratory fluoroquinolone, escalated to cover Pseudomonas or MRSA when risk factors are present.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Pneumonia is an infection of the lung parenchyma, producing a new infiltrate on chest imaging together with an acute lower respiratory syndrome (fever, cough, dyspnea, or chest pain).
- Epidemiology
CAP hospitalization and death rise steeply with age; hospitalization for CAP in adults 80 years or older is 25 times higher than in adults younger than 50 years.
- Risk factors
Age 65 years or older, associated with influenza virus, S.
- Pathophysiology
Organisms most often reach the lower respiratory tract by microaspiration of oropharyngeal secretions, with the balance of organism virulence, inoculum size, and host defenses determining whether infection establishes.
- Clinical features
Fever with cough, dyspnea, or chest pain is the presentation that should trigger suspicion and prompt chest imaging.
- Differential diagnosis
Pulmonary embolism: acute dyspnea and pleuritic pain without a true infiltrate, or a wedge-shaped defect rather than consolidation; CT pulmonary angiography distinguishes it.
- Diagnosis
The diagnosis is established by an acute lower respiratory syndrome plus a new infiltrate on chest imaging; posteroanterior and lateral chest radiography is the recommended initial study, though its…
- Management
First, determine site of care using the PSI or IDSA/ATS criteria with clinical judgment; most patients with CAP are managed safely as outpatients.
- Complications
Nonresolving pneumonia, prompting evaluation for a resistant/atypical organism, a loculated infection, or a noninfectious mimic.
- Prognosis
CAP carries 10% to 12% mortality among hospitalized patients, weighted heavily by age and PSI/IDSA-ATS severity class.
- Prevention
Give the pneumococcal conjugate vaccine followed by the pneumococcal polysaccharide vaccine (PPSV23) to all adults 65 years or older and to younger adults with qualifying chronic conditions, per the…
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Legionella infection (legionellosis)
Legionella pneumophila is an intracellular, water-borne gram-negative bacillus causing severe community-acquired pneumonia with prominent gastrointestinal and hepatic features, confirmed by urinary antigen testing and treated with a macrolide or fluoroquinolone rather than a beta-lactam.
- Haemophilus influenzae infection
Haemophilus influenzae is a gram-negative coccobacillus whose encapsulated type b (Hib) strain historically caused invasive childhood disease (epiglottitis, meningitis, bacteremia) before routine vaccination, while nontypeable strains now dominate as a cause of mucosal infections (otitis media, sinusitis, COPD exacerbation, pneumonia). Epiglottitis is a clinical airway emergency treated by securing the airway before diagnostic workup, and invasive disease is treated with a third-generation cephalosporin.
- Pseudomonas aeruginosa infection
Pseudomonas aeruginosa is a nosocomial, opportunistic gram-negative bacillus that causes hot-tub folliculitis, malignant otitis externa, ventilator-associated pneumonia, febrile-neutropenia bacteremia with ecthyma gangrenosum, and device-associated infections. Empiric therapy requires an antipseudomonal agent and, in resistance-risk or unstable patients, double coverage until susceptibilities return.
- Coccidioidomycosis
Coccidioidomycosis, or valley fever, is a dimorphic fungal infection acquired by inhaling Coccidioides arthroconidia in the southwestern United States, ranging from self-limited pneumonia to disseminated or meningeal disease, diagnosed by culture, histopathology, or serology and treated with fluconazole for symptomatic disease and lifelong fluconazole for meningitis.
- Histoplasmosis
Histoplasma capsulatum is an endemic dimorphic fungus, acquired by inhalation of conidia in the Mississippi and Ohio River valleys and other endemic regions, that most often causes asymptomatic or mild pulmonary infection but can disseminate in immunosuppressed hosts; diagnosis rests on the Histoplasma urinary antigen assay and treatment is itraconazole for mild to moderate disease or liposomal amphotericin B followed by itraconazole for severe or disseminated infection.
- Blastomycosis
Blastomycosis is a dimorphic fungal infection acquired by inhaling Blastomyces dermatitidis conidia in the Mississippi and Ohio River valleys, presenting as primary pulmonary infection that can mimic lung cancer or disseminate to skin and bone, diagnosed by direct fungal stain confirmed with culture, antigen, or serology, and treated with itraconazole for mild to moderate disease or liposomal amphotericin B for severe, disseminated, or CNS disease.
- Aspergillosis
Invasive aspergillosis is an angioinvasive mold infection of neutropenic and immunosuppressed hosts that begins in the respiratory tract and disseminates hematogenously, diagnosed with CT, galactomannan, and biopsy, and treated first-line with voriconazole.
- Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading global cause of infectious death and presents as latent infection, primary/secondary pulmonary disease, or extrapulmonary and disseminated (miliary) disease. Diagnosis rests on AFB smear, NAAT, and mycobacterial culture (the gold standard), and drug-susceptible active disease is treated with a four-drug regimen (isoniazid, rifampin, pyrazinamide, ethambutol) for 2 months followed by isoniazid plus rifampin for 4 to 7 months.
- Bacteremia
Bacteremia is the presence of viable bacteria in the blood, confirmed by positive blood cultures, that ranges from transient and clinically silent to the trigger for sepsis and septic shock requiring urgent source identification and antimicrobial therapy.
- Q fever (Coxiella burnetii infection)
Q fever, caused by inhalation of Coxiella burnetii aerosols from infected livestock, most often produces a self-limited febrile illness with atypical pneumonia or hepatitis, but it is a major cause of culture-negative endocarditis when infection becomes chronic. Acute disease is treated with doxycycline for 2 weeks; endocarditis requires combination therapy for more than 18 months.